SK Chemicals announces the world’s first commercialization approval of tetravalent cell-cultured influenza vaccine

On the 24^th, SK Chemicals(CEO Man-hoon Park) announced acquisition of commercialization approval of ‘SKYCellflu Quadrivalent,’ a tetravalent cell-cultured influence vaccine, from the Ministry of Food and Drug Safety. It is the first time for a tetravalent cell-cultured influenza vaccine to be approved for commercialization in the world.

The approved product features implementation of the next-...